Your browser doesn't support javascript.
loading
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.
Henriksen, Peter A; Hall, Peter; MacPherson, Iain R; Joshi, Shruti S; Singh, Trisha; Maclean, Morag; Lewis, Steff; Rodriguez, Aryelly; Fletcher, Alex; Everett, Russell J; Stavert, Harriet; Broom, Angus; Eddie, Lois; Primrose, Lorraine; McVicars, Heather; McKay, Pam; Borley, Annabel; Rowntree, Clare; Lord, Simon; Collins, Graham; Radford, John; Guppy, Amy; Williams, Michelle C; Japp, Alan; Payne, John R; Newby, David E; Mills, Nicholas L; Oikonomidou, Olga; Lang, Ninian N.
Afiliación
  • Henriksen PA; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
  • Hall P; MRC Institute Genetics and Molecular Medicine, (P.H., H.S., L.P., H.M., O.O.), University of Edinburgh, UK.
  • MacPherson IR; Cancer Research UK, Edinburgh Centre, UK (P.H., H.S., L.P., H.M., O.O.).
  • Joshi SS; Institute of Cancer Sciences, University of Glasgow, UK (I.R.M.).
  • Singh T; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
  • Maclean M; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
  • Lewis S; Edinburgh Clinical Trials Unit, Usher Institute (M.M., S.L., A.R.), University of Edinburgh, UK.
  • Rodriguez A; Edinburgh Clinical Trials Unit, Usher Institute (M.M., S.L., A.R.), University of Edinburgh, UK.
  • Fletcher A; Edinburgh Clinical Trials Unit, Usher Institute (M.M., S.L., A.R.), University of Edinburgh, UK.
  • Everett RJ; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
  • Stavert H; Department of Child Health, University of Glasgow, School of Medicine and Dentistry, UK (A.F.).
  • Broom A; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
  • Eddie L; MRC Institute Genetics and Molecular Medicine, (P.H., H.S., L.P., H.M., O.O.), University of Edinburgh, UK.
  • Primrose L; Cancer Research UK, Edinburgh Centre, UK (P.H., H.S., L.P., H.M., O.O.).
  • McVicars H; Department of Haematology, Western General Hospital, Edinburgh, UK (A.B., L.E.).
  • McKay P; Department of Haematology, Western General Hospital, Edinburgh, UK (A.B., L.E.).
  • Borley A; MRC Institute Genetics and Molecular Medicine, (P.H., H.S., L.P., H.M., O.O.), University of Edinburgh, UK.
  • Rowntree C; Cancer Research UK, Edinburgh Centre, UK (P.H., H.S., L.P., H.M., O.O.).
  • Lord S; MRC Institute Genetics and Molecular Medicine, (P.H., H.S., L.P., H.M., O.O.), University of Edinburgh, UK.
  • Collins G; Cancer Research UK, Edinburgh Centre, UK (P.H., H.S., L.P., H.M., O.O.).
  • Radford J; Department of Haematology, Beatson Oncology Centre, Glasgow, UK (P.M.).
  • Guppy A; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK (A.B.).
  • Williams MC; University Hospital of Wales, Cardiff, UK (C.R.).
  • Japp A; Department of Oncology, University of Oxford, UK (S.L.).
  • Payne JR; Oxford Cancer and Hematology Centre, Churchill Hospital, UK (G.C.).
  • Newby DE; University of Manchester and Christie NHS Foundation, UK (J.R.).
  • Mills NL; Mount Vernon Cancer Centre, Middlesex, UK (A.G.).
  • Oikonomidou O; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
  • Lang NN; BHF Centre for Cardiovascular Science (P.A.H., S.S.J., T.S., A.F., R.J.E., M.C.W., A.J., D.E.N., N.L.M.), University of Edinburgh, UK.
Circulation ; 148(21): 1680-1690, 2023 11 21.
Article en En | MEDLINE | ID: mdl-37746692
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Mama / Antraciclinas Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Mama / Antraciclinas Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido